HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cecile Dorange Selected Research

Phenobarbital (Luminal)

3/2015Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial.
3/2014Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.
3/2014Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study.
10/2012First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cecile Dorange Research Topics

Disease

3Neointima
03/2015 - 10/2012
3Cardiovascular Diseases (Cardiovascular Disease)
06/2014 - 02/2006
2Neoplasms (Cancer)
03/2023 - 10/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2023 - 01/2022
2Coronary Stenosis (Coronary Artery Stenosis)
10/2011 - 08/2007
1Disease Progression
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2012
1Atherosclerotic Plaque (Atheroma)
07/2011
1Ischemia
11/2010
1Myocardial Infarction
08/2007

Drug/Important Bio-Agent (IBA)

4Phenobarbital (Luminal)FDA Link
03/2015 - 10/2012
3NivolumabIBA
03/2023 - 10/2018
3EverolimusFDA Link
11/2012 - 08/2007
2omega-Chloroacetophenone (Mace)IBA
06/2014 - 11/2010
1B7-H1 AntigenIBA
10/2018
1IpilimumabIBA
10/2018
1MetalsIBA
08/2007
1PolymersIBA
08/2007

Therapy/Procedure

5Stents
03/2015 - 08/2007
3Drug Therapy (Chemotherapy)
03/2023 - 10/2018
1Immunotherapy
03/2023
1Adjuvant Chemotherapy
01/2022
1Therapeutics
10/2018
1Length of Stay
02/2006